Mutations in TRAPPC11 are associated with a congenital disorder of glycosylation

Congenital disorders of glycosylation (CDG) are a heterogeneous and rapidly growing group of diseases caused by abnormal glycosylation of proteins and/or lipids. Mutations in genes involved in the homeostasis of the endoplasmic reticulum (ER), the Golgi apparatus (GA), and the vesicular trafficking...

Descripción completa

Detalles Bibliográficos
Autores: Matalonga, L, Bravo, M, Serra-Peinado, C, Garcia-Pelegri, E, Ugarteburu, O, Vidal, S, Llambrich, M, Quintana, E, Fuster-Jorge, P, Gonzalez-Bravo, MN, Beltran, S, Dopazo, J, Garcia-Garcia, F, Foulquier, F, Matthijs, G, Mills, P, Ribes, A, Egea, G, Briones, P, Tort, F, Giros, M
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p13034
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/13034
Access Level:acceso abierto
Palabra clave:CDG
TRAPPC11
Golgi
endoplasmic reticulum
vesicle trafficking
Descripción
Sumario:Congenital disorders of glycosylation (CDG) are a heterogeneous and rapidly growing group of diseases caused by abnormal glycosylation of proteins and/or lipids. Mutations in genes involved in the homeostasis of the endoplasmic reticulum (ER), the Golgi apparatus (GA), and the vesicular trafficking from the ER to the ER-Golgi intermediate compartment (ERGIC) have been found to be associated with CDG. Here, we report a patient with defects in both N- and O-glycosylation combined with a delayed vesicular transport in the GA due to mutations in TRAPPC11, a subunit of the TRAPPIII complex. TRAPPIII is implicated in the anterograde transport from the ER to the ERGIC as well as in the vesicle export from the GA. This report expands the spectrum of genetic alterations associated with CDG, providing new insights for the diagnosis and the understanding of the physiopathological mechanisms underlying glycosylation disorders.